Heart Failure

Latest News

Burden of Mendelian Cardiomyopathy Variants in HF of Ischemic Etiology

Patients with heart failure of mostly ischemic etiology were found to have increased burden of mendelian cardiomyopathy variants compared with control individuals.

Statins May Protect Heart From Chemotherapy in Early Breast Cancer

Risk for heart failure hospital presentations significantly lower in statin-exposed women treated with anthracyclines.

Empagliflozin Under Review for Heart Failure with Reduced Ejection Fraction

The sNDA is supported by data from the phase 3 EMPEROR-Reduced trial which compared the efficacy and safety of empagliflozin to placebo, in addition to recommended therapy, in 3730 patients with chronic heart failure with reduced ejection fraction.

Predicting Response to CRT Upgrade in Patients With Chronic Right Ventricular Pacing

Underlying heart disease and use of ACE inhibitors were found to be significant predictors of response to cardiac resynchronization therapy upgrade in patients with chronic right ventricular pacing.

Same-Day Discharge After PCI: ACC Expert Consensus Decision Pathway

Expert Consensus Decision Pathway provides guidance on same-day discharge of patients who have undergone PCI.

Predictors of Survival After TTVR for Severe Tricuspid Regurgitation With Chronic Heart Failure

Invasive assessment of cardiopulmonary hemodynamics may predict survival after transcatheter tricuspid edge-to-edge valve repair in patients with severe tricuspid regurgitation and symptomatic heart failure.

Early ECMO-Facilitated Resuscitation vs ACLS for OHCA and Refractory Ventricular Fibrillation

In patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation, early extracorporeal membrane oxygenation-facilitated resuscitation was found to improve survival to hospital discharge.

Socioeconomic Status Tied to Survival After In-Hospital Cardiac Arrest

High-SES patients less likely to receive delayed cardiopulmonary resuscitation; more likely to survive CPR, to survive to discharge and to 30 days.

Effect of Empagliflozin on Pulmonary Capillary Wedge Pressure in HFrEF

Researchers’ goal was to determine empagliflozin’s impact on the central hemodynamic parameters of patients with heart failure with reduced ejection fraction.

Lymphatic Reserve in HFpEF

Peripheral lymphatic vessels may not compensate for interstitial accumulation and fluid extravasation in HFpEF.